Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00853996
First received: February 26, 2009
Last updated: May 31, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)